Global Surgery Presentation (December 4, 2024)
* You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
In this presentation, Dr. Sharmila Anandasabapathy discusses her work in global health and gastrointestinal cancer screening, and Dr. Rachel Davis reviews efforts by Baylor College of Medicine to study and partner with international organizations in efforts to improve surgical access and quality worldwide.
This Michael E. DeBakey Department of Surgery Grand Rounds session took place on Wednesday, December 4, 2024 at 7:00 a.m.
Activity Information
How to Claim Credit
You may claim credit after watching this activity.
You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
Needs Statement
Surgeons, advanced practice providers, fellows, residents, and medical students in various surgical specialties and subspecialties need to receive regular updates on advances in surgical care and clinical practices. Novel technologies and procedures will be examined as means to improve the diagnosis and treatment of medical conditions requiring surgical intervention. The series aims to expand the knowledge of learners, enhance surgical skills, increase surgical efficiency, disseminate surgical best practices, and improve surgical outcomes.
Educational Objectives
Global Health and Gastrointestinal Cancers: Technology and Innovation
At the conclusion of the activity, the participants should be able to:
- Identify challenges in delivering gastrointestinal and endoscopic technologies to the world equitably.
- Provide an overview of several novel, portable and point of care approaches to GI cancer screening and early detection, including AI-guided platforms.
- Summarize an overview of novel facilitators and platforms to development of novel GI technologies.
Baylor Global Surgery: A Ten-Year Retrospective
At the conclusion of the activity, the participants should be able to:
- Discuss the problem of global surgery access and quality worldwide.
- Outline the history of Baylor’s global surgery programs and partnerships.
- Identify current global surgery efforts within the college.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Other Health Professionals
Specialties
- Surgery
Interest Groups
- Global Health
Activity Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.
Educational Methods
- Lectures
- Case Presentations
- Literature Review
- Panel Discussion
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Directors
-
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Term of Approval
December 1, 2024 through December 31, 2026. Original release date: December 1, 2024.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Meara JG, Leather AJ, Hagander L, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386(9993):569-624. doi:10.1016/S0140-6736(15)60160-X.
Sherif YA, Erdene S, Khan L, et al. Fidelity in Academic Global Surgery and Research: Incorporating Trustworthiness in the Development of Research Partnerships, Infrastructure, and Policy. J Am Coll Surg. 2024;239(4):400-409. doi:10.1097/XCS.0000000000001104.
Scott EM, Enumah ZO, Mehta K, Kontchou NA, Davis RW. Practical and Ethical Guidelines for the Involvement of Trainees in Global Surgery: Consensus Statement and Recommendations from the Resident and Associate Society of the American College of Surgeons Global Surgery Work Group. J Am Coll Surg. 2023;237(6):885-892. doi:10.1097/XCS.0000000000000864.
Bansal S, Sherif YA, Nuchtern JG, Rosengart TK, Davis RW. A comprehensive curriculum for the American academic global surgery trainee: Addressing an educational need. Am J Surg. 2023;226(5):721-725. doi:10.1016/j.amjsurg.2023.06.016.
Sherif YA, Philipo GS, Makasa EM, Nguyen BU, Dinh LT, Bansal S, Rosengart TK, Davis RW. Globalization of healthcare creates evolving ethical dilemmas. Bull Am Coll Surg. 2023;108(4):12-18.
Sherif YA, Choudhury T, Makasa E, Rosengart TK, Davis RW, Kaseje N. Ethics of Educating American Global Surgeons: An Approach to Conscientious Training on the Individual, Departmental, and Institutional Levels. J Am Coll Surg. 2022;234(2):239-246. doi:10.1097/XCS.0000000000000026.
Davis RW, Sherif YA, Vu MT, et al. Personalized Graduate Medical Education and the Global Surgeon: Training for Resource-Limited Settings. Acad Med. 2021;96(3):384-389. doi:10.1097/ACM.0000000000003898.
Davis RW, Johnson WD. Cross-Cutting Health: Global Surgery, Obstetrics, Anesthesia, and the World Health Organization. Bull Am Coll Surg. 2018;103(5):16-20.
Strauss AL, Falk GW. New Techniques to Screen for Barrett Esophagus. Gastroenterol Hepatol (N Y). 2023;19(7):383-390.
Hicheri C, Azimuddin AM, Kortum A, et al. Design and Evaluation of ScanCap: A Low-Cost, Reusable Tethered Capsule Endoscope with Blue-Green Illumination Imaging for Unsedated Screening and Early Detection of Barrett’s Esophagus. Bioengineering. 2024;11(6):557. doi:10.3390/bioengineering11060557.
Tan MC, Li Z, Patel KK, et al. A high-resolution Microendoscope improves esophageal cancer screening and surveillance: Implications for underserved global settings based on an international randomized controlled trial. Gastroenterology. Published online October 2024. doi:10.1053/j.gastro.2024.10.025.
Protano MA, Xu H, Wang G, et al. Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International Trial. Gastroenterology. 2015;149(2):321-329. doi:10.1053/j.gastro.2015.04.055.
Camara Dit Pinto S, Cherkaoui J, Ghosh D, et al. A virtual scalable model of the hepatic lobule for acetaminophen hepatotoxicity prediction. npj Digital Medicine. 2024;7(1). doi:10.1038/s41746-024-01349-5.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenters
-
Sharmila Anandasabapathy, M.D., AGAF
Professor
Baylor College of Medicine
Disclosure:
- Employment (with a commercial interest): Cyted; Grid X
- Research Support: Adusne
-
Rachel Davis, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
- Research Support: BD
- Consultancy: World Health Organization
Activity Directors
-
Michele Loor, M.D., FACS
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: Ascendis Pharmaceuticals; Corcept Pharmaceuticals
- Intellectual Property (patent rights, royalty payments): Inspectra Diagnostics; MasSpec Pen Technologies
Planning Committee Members
-
William E Fisher, M.D., FACS
Professor, Clinical Vice-Chair and Chief, Division of General Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
John A Goss, M.D.
Professor of Surgery and Chief, Division of Abdominal Transplantation
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Michele Loor, M.D., FACS
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Todd Rosengart, M.D., F.A.C.S.
DeBakey-Bard Chair of Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: XyloCor Therapeutics
- Board Membership: XyloCor Therapeutics; Geoclin Therapeutics
- Ownership Interests (stock, stock options, excluding diversified mutual funds): XyloCor Therapeutics; Geoclin Therapeutics
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: Ascendis Pharmaceuticals; Corcept Pharmaceuticals
- Intellectual Property (patent rights, royalty payments): Inspectra Diagnostics; Mass Spec Pen Technologies